Thomas N. Chase

35.5k citations

394 papers · 27.7k indexed · 5 hit papers · h-index 86

Impact in

Cellular and Molecular Neuroscience top 0.02%
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior
- Genetic Neurodegenerative Diseases
- Neuropeptides and Animal Physiology
Neurology top 0.02%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments

Papers in

Neurology 170
- Parkinson's Disease Mechanisms and Treatments 141
- Neurological disorders and treatments 117
Cellular and Molecular Neuroscience 186
- Neuroscience and Neuropharmacology Research 84
- Neurotransmitter Receptor Influence on Behavior 52
- Neuropeptides and Animal Physiology 37
- Genetic Neurodegenerative Diseases 32

Co-authors: M. Maral Mouradian Erich Mohr Thomas M. Engber Christopher Randolph Justin D. Oh Michael Tierney Zvi Susel Peter Lawrence
Journals: Neurology (43 papers)Brain Research (26 papers)Movement Disorders (21 papers)European Journal of Pharmacology (19 papers)Annals of Neurology (19 papers)
Partner nations: United States Czechia Italy

In The Last Decade

Thomas N. Chase

389 papers receiving 26.6k citations

Hit Papers

5 papers align trajectories log scale

Representing a new MODIS consistent land surface in the Community Land Model (CLM 3.0) 2007 · 504 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2007 Journal of Geophysical Research Atmospheres
2002 Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences
1998 Journal of Clinical and Experimental Neuropsychology
1990 Science
1976 Raven Press eBooks

Peers

Countries citing papers authored by Thomas N. Chase

Since Specialization

Citations

This map shows the geographic impact of Thomas N. Chase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas N. Chase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas N. Chase more than expected).

Fields of papers citing papers by Thomas N. Chase

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas N. Chase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas N. Chase. The network helps show where Thomas N. Chase may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Thomas N. Chase, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas N. Chase Line = papers co-authored together Thomas N. Chase links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Multi‐Component Prehabilitation Program for Older Adults Undergoing Major Elective Surgery: A Pilot and Feasibility Study Journal of the American Geriatrics Society ·J.-C. Marle, Run-Xue Jiang, Yuchen Liu, 傅理, Kristina Trobäck, 曾友平, 马昂, Thomas N. Chase, Valluvan Rangasamy, Maxime Fabre, Sandra Shi, Thomas G. Travison, Balachundhar Subramaniam, Dae Hyun Kim	2025	0
2	Reduced Plasma Levodopa Fluctuations with More Frequent Administration of a Novel Carbidopa/Levodopa Functionally Scored Tablet Clinical Pharmacology in Drug Development ·Thomas N. Chase, Ahmad Al‐Sabbagh, Minako Koga, Meena Seda	2024	0
3	Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer's Disease PMC ·Thomas N. Chase, Martin R. Farlow, Meena Seda	2017	2
4	Are Present Day Climate Simulations Accurate Enough for Reliable Regional Downscaling OpenSIUC (Southern Illinois University Carbondale) ·Thomas N. Chase, Roger A. Pielke, Wing Yin Tse	2011	1
5	Climate Impacts of Potential Vegetation versus Current Day MODIS Land Cover in the Community Climate System Model (CCSM) AGU Fall Meeting Abstracts ·Peter Lawrence, Thomas N. Chase	2007	1
6	Striatal plasticity and extrapyramidal motor dysfunction Parkinsonism & Related Disorders ·Thomas N. Chase	2004	45
7	Mapping of Rat Brain Using the Synuclein-1 Monoclonal Antibody Reveals Somatodendritic Expression of α-Synuclein in Populations of Neurons Homologous to those Vulnerable to Lewy Body Formation in Human Synucleopathies Journal of Neuropathology & Experimental Neurology ·Gerda Andringa, Fu Du, Thomas N. Chase, M. Catherine Bennett	2003	23
8	Nuclear factor kappaB nuclear translocation upregulates c-Myc and p53 expression during NMDA receptor-mediated apoptosis in rat striatum. Europe PMC (PubMed Central) ·Zheng‐Hong Qin, Ren‐Wu Chen, Yumei Wang, Masami Nakai, De‐Maw Chuang, Thomas N. Chase	1999	214
9	The Functional Neuroanatomy of Tourette's Syndrome: An FDG-PET Study. II: Relationships between Regional Cerebral Metabolism and Associated Behavioral and Cognitive Features of the Illness Neuropsychopharmacology ·Allen R. Braun, Christopher Randolph, Simona Švaňová, Erich Mohr, Christine L. Cox, Katalin Vladar, A.M. Olanrewaju, Richard E. Carson, Peter Herscovitch, Thomas N. Chase	1995	14
10	Fluctuations in plasma levodopa and motor responses with liquid and tablet levodopa/carbidopa Movement Disorders ·Leo Verhagen Metman, Jorrit I. Hoff, M. Maral Mouradian, Thomas N. Chase	1994	42
11	The neostriatum and nucleus accumbens in parkinsonism-dementia complex of Guam: a pathological comparison with Alzheimer's disease and progressive supranuclear palsy Acta Neuropathologica ·Kiyomitsu Oyanagi, Takao Makifuchi, Andrew M. Garfield, Kwang-Ming Chen, D. Carleton Gajdusek, Thomas N. Chase, Fusahiro Ikuta	1994	20
12	Treatment of parkinson's disease with the partial dopamine agonist EMD 49980 Movement Disorders ·Daniele Bravi, Thomas L. Davis, M. Maral Mouradian, Thomas N. Chase	1993	15
13	Striatal D1 dopamine receptor morphochemistry following continuous or intermittent l-DOPA replacement therapy Experimental Neurology ·Marjorie A. Ariano, Thomas M. Engber, Zvi Susel, Thomas N. Chase	1991	8
14	Somatostatin replacement therapy for alzheimer dementia Annals of Neurology ·M. Maral Mouradian, J. Blin, Nigusse Kassa, Isabella J.E. Heuser, Fabio Baronti, Logan Ann Lumm, Thomas N. Chase	1991	23
15	Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's disease Annals of Neurology ·M. Maral Mouradian, Isabella J.E. Heuser, Fabio Baronti, Thomas N. Chase	1990	192
16	Supersensitivity to a D-1 dopamine receptor agonist and subsensitivity to a D-2 receptor agonist following chronic D-1 receptor blockade European Journal of Pharmacology ·Paolo Barone, Aśoka Vājapeyī, Sotirios A. Parashos, Thomas N. Chase	1988	24
17	INFLUENCE OF GONADAL STEROIDS ON PROLACTIN RESPONSE TO NALOXONE IN HUMANS Luca Steardo, Palmiero Monteleone, W.F. Watts, Thomas N. Chase, U. Scapagnini	1983	3
18	Daily fluctuation in the concentration on cAMP in the conscious primate brain Brain Research ·Mark J. Perlow, Barry W. Festoff, Edna K. Gordon, Michael H. Ebert, David K. Johnson, Thomas N. Chase	1977	10
19	GABA in nervous system function Raven Press eBooks ·Eugene Roberts, Thomas N. Chase, Donald B. Tower, Communicative Disorders Hit paper breakdown →	1976	380
20	The Clinical neurosciences Raven Press eBooks ·Thomas N. Chase, Donald B. Tower	1975	14

About Thomas N. Chase

Thomas N. Chase is a scholar working on Neurology, Cellular and Molecular Neuroscience, Developmental Neuroscience, Psychiatry and Mental health and Biological Psychiatry, having authored 394 papers that have together received 27.7k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (141 papers), Neurological disorders and treatments (117 papers), Neuroscience and Neuropharmacology Research (84 papers), Neurotransmitter Receptor Influence on Behavior (52 papers), Receptor Mechanisms and Signaling (49 papers), Neuropeptides and Animal Physiology (37 papers), Climate variability and models (36 papers) and Genetic Neurodegenerative Diseases (32 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (12.9k citations), Neurology (10.3k citations), Biological Psychiatry (608 citations), Psychiatry and Mental health (3.4k citations) and Cognitive Neuroscience (3.8k citations). Thomas N. Chase has collaborated with scholars based in United States, Czechia and Italy. Frequent co-authors include M. Maral Mouradian, Erich Mohr, Thomas M. Engber, Christopher Randolph, Justin D. Oh, Michael Tierney, Zvi Susel, Peter Lawrence, Charles R. Gerfen and Allen R. Braun. Their work appears in journals such as Neurology, Brain Research, Movement Disorders, European Journal of Pharmacology and Annals of Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact